Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05327062

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
XSpline S.p.A. (from the registry)
Registry
  • NCT NCT05327062
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Hungary, Italy, Netherlands, Spain, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05327062. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-03-06 (actual); primary completion 2025-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
Acronym
CRT-DRIVE
Condition
Cardiac Resynchronization Therapy
Condition
Chronic Heart Failure
Condition
Left Bundle-Branch Block
Intervention (Device)
CRT implantation guided by XSpline, a non-invasive electrical and venous anatomy assessment
Lead sponsor
XSpline S.p.A. (class: industry)

Record details

Record id
cardio:ct-nct05327062
Content hash
3f211b50d0a0b578e3eeb7cf46b60e28455ec3920115fe618335a01a343c5376